ClinicalTrials.Veeva

Menu

The Role of Laryngopharyngeal Reflux in IPF

National Jewish Health logo

National Jewish Health

Status

Enrolling

Conditions

IPF
Reflux

Study type

Observational

Funder types

Other

Identifiers

NCT03418350
HS-3130

Details and patient eligibility

About

The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).

Full description

The study team hypothesizes the SGI will correlate more strongly with measures of IPF severity (at baseline and over time) than gastroesophageal reflux (GER) data derived from the esophageal detector channels of a pH/impedance probe.

Enrollment

60 estimated patients

Sex

All

Ages

40 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of IPF
  • Age 40-95
  • Able to read, speak, and understand English
  • If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent.

Exclusion criteria

  • Patients who do not meet all inclusion criteria
  • Pregnant females

Trial contacts and locations

1

Loading...

Central trial contact

Matthew Koslow, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems